As of Nov 25
| -0.10 / -1.61%|
The 3 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 7.93, with a high estimate of 8.20 and a low estimate of 7.90. The median estimate represents a +30.08% increase from the last price of 6.10.
The current consensus among 3 polled investment analysts is to Buy stock in Starpharma Holdings Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.